News & Updates

Show Multimedia Only

Novel SYK inhibitor elicits durable Hb response in autoimmune haemolytic anaemia

The highly selective oral spleen tyrosine kinase (SYK) inhibitor sovleplenib has demonstrated significant clinical benefit in patients with warm autoimmune haemolytic anaemia (wAIHA), with durable haemoglobin (Hb) response and a favourable safety profile, as shown in the phase III ESLIM-02 trial.

Novel SYK inhibitor elicits durable Hb response in autoimmune haemolytic anaemia

14 hours ago

Novel cancer vaccine plus pembrolizumab prolongs PFS in advanced melanoma

16 hours ago by

An investigational, immune-modulatory cancer vaccine, IO102-IO103, when combined with pembrolizumab results in sustained progression-free survival (PFS) compared with pembrolizumab alone in patients with advanced melanoma, reports a study.

Novel cancer vaccine plus pembrolizumab prolongs PFS in advanced melanoma

16 hours ago

Fenfluramine works in paediatric, adult patients with developmental/epileptic encephalopathies

22 hours ago

In children and adults with developmental and epileptic encephalopathies (DEEs), treatment with fenfluramine appears to be effective with predictable tolerability, as shown in a real-world study.

Fenfluramine works in paediatric, adult patients with developmental/epileptic encephalopathies

22 hours ago

Co-treatment with yoga plus camelina sativa powder improves outcomes in women with T2D

a day ago

In women with type 2 diabetes (T2D), performing yoga in addition to supplementation with camelina sativa powder (CSP) delivers improvements in glycaemic indices, oxidative stress, and inflammatory markers, according to a study.

Co-treatment with yoga plus camelina sativa powder improves outcomes in women with T2D

a day ago

Sugary drinks, fruit juice implicated in hypertension

a day ago by

Drinking excessive amounts of sugar sweetened beverages and fruit juice has been shown to raise the risk of hypertension, regardless of overall diet quality and physical activity, in a large prospective study.

Sugary drinks, fruit juice implicated in hypertension

a day ago

Undernutrition may worsen survival outcomes in cancer patients

a day ago

Undernutrition appears to reduce overall survival (OS) in patients with cancer, suggests a recent study.

Undernutrition may worsen survival outcomes in cancer patients

a day ago

CheckMate 214: Nivolumab-ipilimumab remains standard of care as first-line treatment in aRCC

a day ago by

Combination therapy with nivolumab and ipilimumab provides sustained survival benefit with durable responses compared with sunitinib for the first-line treatment of advanced renal cell carcinoma (aRCC), as shown by the phase III CheckMate 214 trial.

CheckMate 214: Nivolumab-ipilimumab remains standard of care as first-line treatment in aRCC

a day ago

Link between protein type, mortality differs by sex, adiposity

a day ago

Sex, smoking status, and adiposity mediate the associations between dietary animal (AP) and plant proteins (PP) and mortality, reports a study.

Link between protein type, mortality differs by sex, adiposity

a day ago

1-year fixed-duration venetoclax-obinutuzumab goes a long way in CLL

a day ago by

The final results of the CLL14 trial validate the long-term efficacy of 1-year fixed-duration venetoclax plus obinutuzumab in previously untreated patients with chronic lymphocytic leukaemia (CLL) and co-existing conditions.

1-year fixed-duration venetoclax-obinutuzumab goes a long way in CLL

a day ago

Okra supplementation may lower cardiovascular risk in prediabetes, T2D, diabetic nephropathy

a day ago

Okra supplementation is beneficial to patients with prediabetes, type 2 diabetes (T2D), or diabetic nephropathy, conferring beneficial effects on lipid profile, diastolic BP, and inflammation markers, according to a systematic review and meta-analysis.

Okra supplementation may lower cardiovascular risk in prediabetes, T2D, diabetic nephropathy

a day ago

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Novel SYK inhibitor elicits durable Hb response in autoimmune haemolytic anaemia

Novel SYK inhibitor elicits durable Hb response in autoimmune haemolytic anaemia

Novel cancer vaccine plus pembrolizumab prolongs PFS in advanced melanoma

Novel cancer vaccine plus pembrolizumab prolongs PFS in advanced melanoma

Fenfluramine works in paediatric, adult patients with developmental/epileptic encephalopathies

Fenfluramine works in paediatric, adult patients with developmental/epileptic encephalopathies

Co-treatment with yoga plus camelina sativa powder improves outcomes in women with T2D

Co-treatment with yoga plus camelina sativa powder improves outcomes in women with T2D

Sugary drinks, fruit juice implicated in hypertension

Sugary drinks, fruit juice implicated in hypertension

Undernutrition may worsen survival outcomes in cancer patients

Undernutrition may worsen survival outcomes in cancer patients

CheckMate 214: Nivolumab-ipilimumab remains standard of care as first-line treatment in aRCC

CheckMate 214: Nivolumab-ipilimumab remains standard of care as first-line treatment in aRCC

Link between protein type, mortality differs by sex, adiposity

Link between protein type, mortality differs by sex, adiposity

1-year fixed-duration venetoclax-obinutuzumab goes a long way in CLL

1-year fixed-duration venetoclax-obinutuzumab goes a long way in CLL

Okra supplementation may lower cardiovascular risk in prediabetes, T2D, diabetic nephropathy

Okra supplementation may lower cardiovascular risk in prediabetes, T2D, diabetic nephropathy